CS
LEXXW

Clear Street’s Lexaria Bioscience Warrant LEXXW Stock Holding History

Clear Street’s Portfolio LEXXW Stock Details LEXXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-200
Closed -$1 – 1141
2025
Q4 		$1 Buy
200
+100
+100% +$4 ﹤0.01% 927
2025
Q3 		$8 Buy
+100
New +$12 ﹤0.01% 835
2025
Q1 		– Sell
-100
Closed -$76 – 590
2024
Q4 		$76 Sell
100
-100
-50% -$78 ﹤0.01% 548
2024
Q3 		$184 Buy
200
+100
+100% +$115 ﹤0.01% 657
2024
Q2 		$81 Hold
100
– – ﹤0.01% 742
2024
Q1 		$150 Buy
+100
New +$95 ﹤0.01% 722

Clear Street's LEXXW Position: Q1 2026 in Review

Clear Street sold out of Lexaria Bioscience Warrant (LEXXW) in Q1 2026, closing a stake of 200 shares — an estimated $1 sold.

Clear Street first reported a position in LEXXW in Q1 2024 and held it in 6 quarters. The position peaked at $184 in Q3 2024. 0 funds tracked by Wall St. Rank hold LEXXW as of Q1 2026.

  • Clear Street reported no remaining Lexaria Bioscience Warrant position as of Q1 2026 after selling out during the quarter.
  • Clear Street sold 200 Lexaria Bioscience Warrant shares in Q1 2026, an estimated $1.
  • Clear Street first reported a position in Lexaria Bioscience Warrant in Q1 2024 and held it in 6 quarters.
  • Clear Street's Lexaria Bioscience Warrant position peaked at $184 in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Lexaria Bioscience Warrant as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.